miRNA counts identified by RNA seq in the caudate nucleus of patients neuropathologically diagnosed with late-onset Alzheimer's disease (non-carriers and carriers of intermediate expansions in the HTT gene) and healthy subjects.

These data include individual miRNA counts identified by RNA-seq in post mortem caudate nucleus samples. Samples with identifier A belong to patients with a neuropathological diagnosis of late-onset Alzheimer's disease. Group B samples belong to patients with the same neuropathological diagnosis, but carrying CAG expansions in the intermediate range (27-35 CAG) in the HTT gene. Finally, group C samples belong to healthy subjects without neuropathological diagnosis.